| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8766257 | La Presse Médicale | 2018 | 9 Pages |
Abstract
The association sacubitril/valsartan is a new treatment of chronic cardiac failure, acting through the decrease of ANP catabolism.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kanza Benomar, Stéphanie Espiard, Camille Loyer, Arnaud Jannin, Marie-Christine Vantyghem,